| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0010346|crohn disease |
| Sentences | 1 |
| PubMedID- 20837778 | We evaluated the safety and clinical outcome of autologous nonmyeloablative hematopoietic stem cell transplantation (hsct) in patients with severe crohn disease (cd) defined as a crohn disease activity index (cdai) greater than 250, and/or crohn severity index greater than 16 despite anti-tumor necrosis factor therapy. |
Page: 1